- Home
- ESPR vs IHRT Comparison
ESPR vs IHRT Comparison
Compare ESPR & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- IHRT
- Stock Information
- Founded
- ESPR 2008
- IHRT N/A
- Country
- ESPR United States
- IHRT United States
- Employees
- ESPR N/A
- IHRT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- IHRT Broadcasting
- Sector
- ESPR Health Care
- IHRT Consumer Discretionary
- Exchange
- ESPR Nasdaq
- IHRT Nasdaq
- Market Cap
- ESPR 319.2M
- IHRT 296.6M
- IPO Year
- ESPR 2013
- IHRT 2019
- Fundamental
- Price
- ESPR $2.33
- IHRT $2.33
- Analyst Decision
- ESPR Buy
- IHRT Hold
- Analyst Count
- ESPR 4
- IHRT 4
- Target Price
- ESPR $8.17
- IHRT $2.00
- AVG Volume (30 Days)
- ESPR 3.4M
- IHRT 893.9K
- Earning Date
- ESPR 11-07-2024
- IHRT 11-07-2024
- Dividend Yield
- ESPR N/A
- IHRT N/A
- EPS Growth
- ESPR N/A
- IHRT N/A
- EPS
- ESPR N/A
- IHRT N/A
- Revenue
- ESPR $295,451,000.00
- IHRT $3,803,046,000.00
- Revenue This Year
- ESPR $199.60
- IHRT $6.56
- Revenue Next Year
- ESPR $19.36
- IHRT N/A
- P/E Ratio
- ESPR N/A
- IHRT N/A
- Revenue Growth
- ESPR 187.12
- IHRT N/A
- 52 Week Low
- ESPR $0.87
- IHRT $0.81
- 52 Week High
- ESPR $3.40
- IHRT $3.12
- Technical
- Relative Strength Index (RSI)
- ESPR 54.58
- IHRT 62.10
- Support Level
- ESPR $2.05
- IHRT $1.68
- Resistance Level
- ESPR $2.25
- IHRT $2.84
- Average True Range (ATR)
- ESPR 0.12
- IHRT 0.19
- MACD
- ESPR -0.00
- IHRT 0.02
- Stochastic Oscillator
- ESPR 61.54
- IHRT 53.78
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.